Larimar Therapeutics, Inc.
LRMR
Revenue
0.00
0.000.00%
3 Months ChangeAssets
187.35M
▲37.36M▲24.91%
3 Months ChangeLiabilities
48.31M
▲18.18M▲60.32%
3 Months ChangeFree Cash Flow
-26.59M
▼-17.61M▼-196.12%
60 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-09
Form 8-K
ID: 0001193125-26-098493
2026-02-27
Form 8-K
ID: 0001193125-26-077646
2026-02-24
Form 8-K
ID: 0001193125-26-065186
2026-01-22
Form 8-K
ID: 0001193125-26-018664
2026-01-12
Form 8-K
ID: 0001193125-26-010409
2025-12-17
Form 8-K
ID: 0001193125-25-321738
2025-11-10
Form 8-K
ID: 0001193125-25-273217
2025-11-05
Form 10-Q
ID: 0001193125-25-266969
2025-11-05
Form 8-K
ID: 0001193125-25-265702
2025-10-14
Form 8-K
ID: 0001193125-25-237998